Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
13 01 2021
Historique:
received: 18 09 2020
accepted: 25 10 2020
pubmed: 5 11 2020
medline: 23 1 2021
entrez: 4 11 2020
Statut: epublish

Résumé

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibody responses to the spike (S) protein monomer, S protein native trimeric form, or the nucleocapsid (N) proteins were evaluated in cohorts of individuals with acute infection (

Identifiants

pubmed: 33144321
pii: JVI.01828-20
doi: 10.1128/JVI.01828-20
pmc: PMC7925109
pii:
doi:

Substances chimiques

Antibodies, Viral 0
Coronavirus Nucleocapsid Proteins 0
Immunoglobulin A 0
Immunoglobulin G 0
Phosphoproteins 0
Spike Glycoprotein, Coronavirus 0
nucleocapsid phosphoprotein, SARS-CoV-2 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 Fenwick et al.

Références

J Clin Virol. 2021 Jan;134:104690
pubmed: 33253926
Euro Surveill. 2020 Jan;25(3):
pubmed: 31992387
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Virus Res. 2014 Dec 19;194:175-83
pubmed: 24670324
N Engl J Med. 2007 Sep 13;357(11):1162-3
pubmed: 17855683
Lancet. 2020 May 23;395(10237):1595-1598
pubmed: 32380041
Isr Med Assoc J. 2020 Apr;22(4):203-210
pubmed: 32286019
Emerg Microbes Infect. 2020 Dec;9(1):1497-1505
pubmed: 32529906
J Clin Virol. 2020 Aug;129:104480
pubmed: 32505777
J Clin Virol. 2020 Jul;128:104413
pubmed: 32403010
Nat Med. 2020 Jun;26(6):849-854
pubmed: 32382154
Emerg Infect Dis. 2007 Oct;13(10):1562-4
pubmed: 18258008
Clin Infect Dis. 2020 Nov 19;71(16):2027-2034
pubmed: 32221519
Science. 2020 Mar 13;367(6483):1260-1263
pubmed: 32075877
Future Microbiol. 2016;11(3):403-25
pubmed: 27028061
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Emerg Infect Dis. 2016 Oct;22(10):1824-6
pubmed: 27332149
Emerg Infect Dis. 2017 Jul;23(7):1079-1084
pubmed: 28585916
Emerg Infect Dis. 2020 Jul;26(7):1478-1488
pubmed: 32267220
Nat Med. 2020 Jun;26(6):823-824
pubmed: 32382153
N Engl J Med. 2003 Jul 31;349(5):508-9
pubmed: 12890855

Auteurs

Craig Fenwick (C)

Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Antony Croxatto (A)

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Alix T Coste (AT)

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Florence Pojer (F)

Protein Production and Structure Core Facility, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Cyril André (C)

Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Céline Pellaton (C)

Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Alex Farina (A)

Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Jérémy Campos (J)

Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

David Hacker (D)

Protein Production and Structure Core Facility, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Kelvin Lau (K)

Protein Production and Structure Core Facility, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland.

Berend-Jan Bosch (BJ)

Virology Section, Infectious Diseases and Immunology Division, Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, The Netherlands.

Semira Gonseth Nussle (S)

Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.

Murielle Bochud (M)

Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.

Valerie D'Acremont (V)

Centre for Primary Care and Public Health, University of Lausanne, Lausanne, Switzerland.

Didier Trono (D)

School of Life Sciences, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.

Gilbert Greub (G)

Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland gilbert.greub@chuv.ch giuseppe.pantaleo@chuv.ch.
Service of Infectious Diseases, Lausanne University Hospital, Lausanne, Switzerland.

Giuseppe Pantaleo (G)

Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland gilbert.greub@chuv.ch giuseppe.pantaleo@chuv.ch.
Swiss Vaccine Research Institute, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH